{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T23:43:55Z","timestamp":1783122235149,"version":"3.54.6"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,29]],"date-time":"2024-09-29T00:00:00Z","timestamp":1727568000000},"content-version":"am","delay-in-days":364,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007496","name":"Biomedical Laboratory Research and Development, VA Office of Research and Development","doi-asserted-by":"publisher","award":["BX004594"],"award-info":[{"award-number":["BX004594"]}],"id":[{"id":"10.13039\/100007496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018576","name":"University Hospitals Harrington Discovery Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018576","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019486","name":"Biocodex Microbiota Foundation","doi-asserted-by":"publisher","award":["403224013 \u2013 SFB 1382"],"award-info":[{"award-number":["403224013 \u2013 SFB 1382"]}],"id":[{"id":"10.13039\/100019486","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K12 HD85036"],"award-info":[{"award-number":["K12 HD85036"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 DK120515"],"award-info":[{"award-number":["P30 DK120515"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50 AA011999"],"award-info":[{"award-number":["P50 AA011999"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AA24726"],"award-info":[{"award-number":["R01 AA24726"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 AA026939"],"award-info":[{"award-number":["U01 AA026939"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005347","name":"American Association for the Study of Liver Diseases","doi-asserted-by":"publisher","award":["R01 AA020703"],"award-info":[{"award-number":["R01 AA020703"]}],"id":[{"id":"10.13039\/100005347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["LA 4286\/1-1"],"award-info":[{"award-number":["LA 4286\/1-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003495","name":"Hessisches Ministerium f\u00fcr Wissenschaft und Kunst","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003495","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hepatobiliary & Pancreatic Diseases International"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.hbpd.2023.05.003","type":"journal-article","created":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T02:04:57Z","timestamp":1683597897000},"page":"474-481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Fecal cytolysin does not predict disease severity in acutely decompensated cirrhosis and acute-on-chronic liver failure"],"prefix":"10.1016","volume":"22","author":[{"given":"Phillipp","family":"Hartmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Schierwagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Praktiknjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonel","family":"Trebicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Schnabl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hbpd.2023.05.003_bib0001","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/cld.685","article-title":"Risk factors for progression of and treatment options for NAFLD in children","volume":"11","author":"Hartmann","year":"2018","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"10.1016\/j.hbpd.2023.05.003_bib0002","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1055\/s-0040-1719174","article-title":"New developments in microbiome in alcohol-associated and nonalcoholic fatty liver disease","volume":"41","author":"Hartmann","year":"2021","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.hbpd.2023.05.003_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.893074","article-title":"Editorial: The microbiome in hepatobiliary and intestinal disease","volume":"13","author":"Hartmann","year":"2022","journal-title":"Front Physiol"},{"key":"10.1016\/j.hbpd.2023.05.003_bib0004","doi-asserted-by":"crossref","first-page":"G563","DOI":"10.1152\/ajpgi.00370.2018","article-title":"Gut microbiota in liver disease: too much is harmful, nothing at all is not helpful either","volume":"316","author":"Hartmann","year":"2019","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.hbpd.2023.05.003_bib0005","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.jhep.2021.11.029","article-title":"The fecal mycobiome in non-alcoholic fatty liver disease","volume":"76","author":"Demir","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2023.05.003_bib0006","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.jhep.2022.12.006","article-title":"Fungal infections and the fungal microbiome in hepatobiliary disorders","volume":"78","author":"Hartmann","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2023.05.003_bib0007","doi-asserted-by":"crossref","first-page":"e0029","DOI":"10.1097\/HC9.0000000000000029","article-title":"Malassezia restricta promotes alcohol-induced liver injury","volume":"7","author":"Zeng","year":"2023","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.hbpd.2023.05.003_bib0008","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.699253","article-title":"Dynamic changes of the fungal microbiome in alcohol use disorder","volume":"12","author":"Hartmann","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.hbpd.2023.05.003_bib0009","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1002\/hep4.1947","article-title":"Intestinal virome in patients with alcohol use disorder and after abstinence","volume":"6","author":"Hsu","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.hbpd.2023.05.003_bib0010","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1053\/j.gastro.2020.07.005","article-title":"Intestinal virome signature associated with severity of nonalcoholic fatty liver disease","volume":"159","author":"Lang","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hbpd.2023.05.003_bib0011","doi-asserted-by":"crossref","DOI":"10.1007\/s10620-023-07860-1","article-title":"Differences in bacterial translocation and liver injury in ethanol versus diet-induced liver disease","author":"Hsu","year":"2023","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.hbpd.2023.05.003_bib0012","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/acer.12704","article-title":"Alcoholic liver disease: the gut microbiome and liver cross talk","volume":"39","author":"Hartmann","year":"2015","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.hbpd.2023.05.003_bib0013","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fphys.2012.00402","article-title":"The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease","volume":"3","author":"Hartmann","year":"2012","journal-title":"Front Physiol"},{"key":"10.1016\/j.hbpd.2023.05.003_bib0014","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/intimm\/dxac030","article-title":"Liver cirrhosis and immune dysfunction","volume":"34","author":"Hasa","year":"2022","journal-title":"Int Immunol"},{"key":"10.1016\/j.hbpd.2023.05.003_bib0015","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41586-019-1742-x","article-title":"Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease","volume":"575","author":"Duan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.hbpd.2023.05.003_bib0016","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/liv.14377","article-title":"Cytolysin-positive Enterococcus faecalis is not increased in patients with non-alcoholic steatohepatitis","volume":"40","author":"Lang","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.hbpd.2023.05.003_bib0017","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hbpd.2023.05.003_bib0018","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jhep.2020.11.019","article-title":"PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis","volume":"74","author":"Trebicka","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2023.05.003_bib0019","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1136\/gutjnl-2017-314240","article-title":"Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis","volume":"67","author":"Fern\u00e1ndez","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.hbpd.2023.05.003_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0256473","article-title":"Role of circulating angiogenin levels in portal hypertension and TIPS","volume":"16","author":"Queck","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.hbpd.2023.05.003_bib0021","doi-asserted-by":"crossref","DOI":"10.1097\/HEP.0000000000000324","article-title":"Immunoglobulin Y antibodies against cytolysin reduce ethanol-induced liver disease in mice","author":"Cabr\u00e9","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2023.05.003_bib0022","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jhep.2014.11.012","article-title":"The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure","volume":"62","author":"Jalan","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2023.05.003_bib0023","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jhep.2014.06.012","article-title":"Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure","volume":"61","author":"Jalan","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2023.05.003_bib0024","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s13054-018-2156-0","article-title":"Validation of CLIF-C ACLF score to define a threshold for futility of intensive care support for patients with acute-on-chronic liver failure","volume":"22","author":"Engelmann","year":"2018","journal-title":"Crit Care"},{"key":"10.1016\/j.hbpd.2023.05.003_bib0025","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ijantimicag.2013.12.008","article-title":"In vitro activity of rifaximin against isolates from patients with small intestinal bacterial overgrowth","volume":"43","author":"Pistiki","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.hbpd.2023.05.003_bib0026","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/jgh3.12596","article-title":"Rifaximin ameliorates intestinal inflammation in cirrhotic patients with hepatic encephalopathy","volume":"5","author":"Tamai","year":"2021","journal-title":"JGH Open"}],"container-title":["Hepatobiliary & Pancreatic Diseases International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387223000735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387223000735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:45:05Z","timestamp":1761493505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499387223000735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S1499387223000735"],"URL":"https:\/\/doi.org\/10.1016\/j.hbpd.2023.05.003","relation":{},"ISSN":["1499-3872"],"issn-type":[{"value":"1499-3872","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fecal cytolysin does not predict disease severity in acutely decompensated cirrhosis and acute-on-chronic liver failure","name":"articletitle","label":"Article Title"},{"value":"Hepatobiliary & Pancreatic Diseases International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hbpd.2023.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}